| Phase 11 trial |
|
Phase 1
|
NCT05533463 |
Sep 2022 → Jun 2024 overdue |
— |
Jiangsu HengRui Medicine Co., Ltd. |
Active not recruiting
|
No outcome recorded
|
| Phase 1/25 trials |
|
Phase 1/2
|
NCT06955390 |
May → Dec 2025 overdue |
cancer |
Henan Cancer Hospital |
Not yet recruiting
|
No outcome recorded
|
|
Phase 1/2
|
NCT06773130 |
Feb 2025 → Aug 2026 overdue |
pancreatic ductal adenocarcinoma |
West China Hospital |
Active not recruiting
|
No outcome recorded
|
|
Phase 1/2
|
NCT06520488 |
Aug 2024 → Mar 2027 expected |
cancer |
Jiangsu HengRui Medicine Co., Ltd. |
Recruiting
|
No outcome recorded
|
|
Phase 1/2
|
NCT06385678 |
Jul 2024 → Dec 2025 overdue |
— |
Jiangsu HengRui Medicine Co., Ltd. |
Active not recruiting
|
No outcome recorded
|
|
Phase 1/2
|
NCT06427239 |
Jun 2024 → Jun 2027 expected |
malignant pancreatic neoplasm |
Fudan University |
Recruiting
|
No outcome recorded
|
| Phase 210 trials |
|
Phase 2
|
NCT07691593 |
Jun 2026 → Oct 2027 expected |
malignant pancreatic neoplasm |
Changhai Hospital |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07503639 |
Apr 2026 → Apr 2028 expected |
colorectal cancer |
Fudan University |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07240766 |
Feb 2026 → May 2027 expected |
adenocarcinoma |
Zhejiang University |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07438106 |
Jan 2026 → Oct 2027 expected |
— |
The First Affiliated Hospital with Nanjing Medical University |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07131514 |
Aug 2025 → Jun 2027 expected |
malignant pancreatic neoplasm |
Ruijin Hospital |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06938282 |
May 2025 → Apr 2027 expected |
malignant pancreatic neoplasm |
Shanghai Zhongshan Hospital |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06770452 |
Mar 2025 → Feb 2027 expected |
carcinoma |
Zhejiang University |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06587061 |
Dec 2024 → Jun 2027 expected |
malignant pancreatic neoplasm |
Ruijin Hospital |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06620848 |
Nov 2024 → Dec 2026 expected |
biliary tract cancer |
Shanghai Zhongshan Hospital |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06547736 |
Oct 2024 → Mar 2027 expected |
malignant pancreatic neoplasm |
Fudan University |
Recruiting
|
No outcome recorded
|
| Phase 31 trial |
|
Phase 3
|
NCT07232875 |
Nov 2025 → Apr 2029 expected |
— |
Jiangsu HengRui Medicine Co., Ltd. |
Recruiting
|
No outcome recorded
|